Gilead suffers defeat at PTAB in government PrEP battle

06-02-2020

Rory O'Neill

Gilead suffers defeat at PTAB in government PrEP battle

II Studio / Shutterstock.com

Gilead has suffered a blow in its efforts to invalidate the US government’s patent rights for PrEP, as the Patent Trial and Appeal Board (PTAB) threw out two of its four patent challenges.


Gilead, Patent Trial and Appeal Board, US Patent and Trademark Office, USPTO, Alex Azar, PrEP, HIV, Truvada, Descovy

LSIPR